Navigation Links
Pinnacle Biologics beantragt Zulassung neuer Indikationen in Deutschland und Frankreich
Date:12/5/2012

AMSTERDAM und BANNOCKBURN, Illinois, 5. Dezember 2012 /PRNewswire/ -- Pinnacle Biologics, BV. hat heute bekanntgegeben, dass es Zulassungsanträge neuer Indikationen bei den deutschen und französischen Gesundheitsbehörden, dem Bundesinstitut für Arzneimittel und Medizinprodukte bzw. der Nationalen Behörde für die Sicherheit von Arzneimitteln und Medizinprodukten (Agence nationale de sécurité de médicaments et des produits de santé) eingereicht hat. Diese beziehen sich auf die Photodynamische Therapie (PDT) mit PHOTOFRIN® (Porfimer-Natrium) für die therapeutische Indikation inoperabler, fortgeschrittener hilärer Cholangiokarzinome (CCA). Pinnacle ist ein Unternehmen für biopharmazeutische Technologie, das neuartige Therapien für die Onkologie und seltene Erkrankungen entwickelt und herstellt.

Die hiläre CCA (Klatskintumor) der oben genannten Indikation ist eine seltene Untergruppe der Krebserkrankungen, die am Konvergenzpunkt des rechten und linken Lebergangs auftritt[1].

„Die Zulassungsanträge spiegeln unser kontinuierliches Engagement wider, um die PDT-Therapie den Medizinern und Patienten weltweit zugänglich zu machen und - was noch wichtiger ist - weiterhin Therapien zu entwickeln, die seltene Erkrankungen wie das Cholangiokarzinom behandeln", sagte Guillermo Herrera, Vorstandsvorsitzender und CEO von Pinnacle.

Über Photodynamische Therapie (PDT) und PHOTOFRIN

Die Photodynamische Therapie mit PHOTOFRIN ist ein zweistufiger Prozess, der sowohl die Anwendung von Licht als auch die Verabreichung des Medikaments erfordert. In der ersten Stufe der PDT wird PHOTOFRIN intravenös verabreicht. In der zweiten Therapiestufe nach der Injektion mit PHOTOFRIN wird dann Belichtung mit nicht-Wärme-Laserlicht über 40 bis 50 Stunden verwendet. Bei Injektion wird PHOTOFRIN  von bestimmtem Gewebe angezogen, vor allem von
'/>"/>

SOURCE Pinnacle Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
2. Pinnacle Biologics acquires PDT laser technology
3. Pinnacle Biologics dépose une nouvelle indication pharmaceutique en Allemagne et en France
4. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
5. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
6. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
7. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
8. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
9. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
10. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
11. CMC Biologics Acquires XOMAs Bay Area Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a ... it has entered into new agreements covering its supply ... the kidney care division of DaVita Healthcare Partners Inc. ... the use of products for home hemodialysis in ... a second amended and restated National Service Provider Agreement ...
(Date:5/21/2013)... 2013   Regulus Therapeutics Inc . ( NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... Operating Officer and Executive Vice President, Finance, will present ... Healthcare Conference on Wednesday, May 29, 2013 at 3:30 ... Westin Boston Waterfront Hotel. The presentation will ...
(Date:5/21/2013)... and PHILADELPHIA , May 21, 2013 /PRNewswire/ ... new corporate image and impressive new product developments at the ... . "After ten years of unerring focus on product literature ... the need to mark the occasion," said founding director ... have some interesting developments of benefit to our clients and ...
Breaking Medicine Technology:NxStage Announces New Agreements with DaVita 2Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3
... CHICAGO, Oct. 28 The non-profit Midwest Business Group ... with numerous local and national organizations, have launched a health ... personal contact to help people improve and manage health conditions. ... ) information series will run through the end of ...
... 28 Amira Pharmaceuticals, Inc. announced today that it ... a novel LPA1 antagonist, in normal, healthy subjects. ... exploring the therapeutic value of AM152, a potentially novel ... safety, pharmacodynamic (PD) and pharmacokinetic (PK) profile of this ...
Cached Medicine Technology:New 'Take Control of Your Health' Education Series to Improve Health of Chicagoans 2Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist 2
(Date:5/21/2013)... Paris, France: One-year results from SOURCE XT one ... registries to-date reported today at EuroPCR 2013 show ... rates of device success for all access approaches, valve ... Study followed up 2688 consecutively enrolled patients (mean age ... valve at 93 centres in 17 countries between July ...
(Date:5/21/2013)... stent, which is a novel stent platform eluting ... the Xience Prime everolimus-eluting stent for the primary ... nine months in the results of an imaging ... BIOFLOW-II substudy used intravascular ultrasound (IVUS) and optical ... and stent apposition at nine months after treating ...
(Date:5/21/2013)... Arizona State University is seeking ... develop their ideas into solutions, products and services ... university is recruiting participants for AREA48 (Applied Regional ... provides early-stage entrepreneurs with opportunities to access human ... anyone, ASU is particularly seeking participation from retirees, ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 According to ... to Rethink the Use of Botox,” Botox injections ... since their approval in 2002 (Go to goo.gl/8iYbD). Although it ... quite popular with men. The injection makes facial wrinkles less ... Botox injection last for about three months. This means that ...
(Date:5/21/2013)... The federal judge overseeing the litigation ... lawsuits in U.S. District Court, Northern District of Georgia, ... from Plaintiffs’ Counsel to conduct Ex Parte interviews with ... Order grants that request, and sets forth procedures under ... Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, ...
Breaking Medicine News(10 mins):Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3
... cuts readmissions , , WEDNESDAY, May 6 (HealthDay News) -- ... airway pressure (CPAP) may help improve outcomes in patients ... CPAP is commonly used to treat sleep apnea. ... Chest , included 232 cardiac surgery patients who ...
... Former McKesson executive to lead further innovation of ... government agencies and wellness companiesBEDFORD, Mass., May 6 ... management software solutions, today announced that Bill Wisotzkey ... and design, effective immediately. Wisotzkey has more than ...
... outbreak in Mexico, the Foreign and Commonwealth Office (FCO) is advising against ... it will consider all claims for cancelled holidays to the country, scheduled ... ... (PRWEB) -- In the wake of the swine flu outbreak in Mexico, ...
... PHILADELPHIA, May 6 The Mobile Massage Team ( ... services for corporate wellness programs, promotional events, and special affairs, ... exhibitor at the 3rd Annual GlobalFit Worksite Wellness Summit ( ... 14, 2009 at The Down Town Club in Center City ...
... conference focused on promoting physical activity on college ... on connecting health care providers and the public ... infiltrating college campuses nationwide. The American College of ... On Campus," a program component to address and ...
... Against Tobacco Recognized Nationally--WASHINGTON, May 6 ... named Youth Advocates of the Year by the Campaign ... fight against tobacco. Members of REAL are being honored ... the nation,s capital tonight (May 6) along with a ...
Cached Medicine News:Health News:Casenet Names Bill Wisotzkey Vice President of Product Management and Design 2Health News:Sainsbury's Travel Insurance will Consider Claims for Cancelled Holidays to Mexico 2Health News:Sainsbury's Travel Insurance will Consider Claims for Cancelled Holidays to Mexico 3Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 2Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 3Health News:Campaign for Tobacco-Free Kids Honors REAL of Hawai'i As Youth Advocates of the Year 2
Jayle tying forceps, straight....
Troutman tying forceps are curved, delicate, bullet shape, with tying platforms. Flat pattern. Ultra fine platforms ideal for 10-0 or 11-0 suture material. Platforms fully meet to hold suture firmly....
Gerl titanium tying forceps has curved shanks, smooth jaws and 6 mm long tying platform. For 8-0 to 11-0 sutures....
Harms tying forceps, standard, straight with smooth jaws. For 7-0 to 9-0 sutures....
Medicine Products: